TrialJournal for immunotherapy of cancer2026

Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer.

John Michael Bryant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.